跳至主要内容
临床试验/CTRI/2023/11/059554
CTRI/2023/11/059554尚未招募2 期

Evaluation Of Efficacy Of Majoon Dabeedul Ward(Sugarfree) In the management of NAFLD using quantitative fat measurement by Shearwarve Imaging - NI

Jamia Hamdard0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
Jamia Hamdard

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age 18-60 years
  • Patient of all genders
  • Patient willing to participate and sign the written informed consent
  • Patient diagnosed as having fatty liver based on the ultrasonography report
  • Patients with/ without clinical signs and symptoms

排除标准

  • Age below 18 and above 60 years
  • Use of alcohol or any other drug abuse
  • Patients diagnosed with any coexisting liver disease
  • Pregnant and lactating women
  • Patients suffering with Hypertension, CKD, CAD, CLD or uncontrolled DM,thyroid disorder.
  • Patient having immune-compromised status.
  • Patient using lipid lowering drugs or dietary supplements within the last 3 weeks.
  • Oral contraceptives & corticosteroids.
  • Neurological disorders like epilepsy or psychiatric disorders
  • Patient having history of Pancreatitis

研究者

发起方
Jamia Hamdard

相似试验